Gemcitabine in advanced pancreatic cancer: A phase II trial

被引：0
|
作者：
Crino, L [1 ]
Mosconi, AM [1 ]
Calandri, C [1 ]
Corgna, E [1 ]
Darwish, S [1 ]
Tonato, M [1 ]
机构：
[1] DIV MED ONCOL,PERUGIA,ITALY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1266 / 1266
页数：1
相关论文
共 50 条
  • [1] Gemcitabine in advanced pancreatic cancer -: A phase II trial
    Crinò, L
    Mosconi, AM
    Calandri, C
    Corgna, E
    Porrozzi, S
    Chiara, S
    Nobili, MT
    Tonato, M
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 296 - 298
  • [2] A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
    Choi, Jong Gwon
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Chul Won
    Kim, Jun Suk
    [J]. CANCER RESEARCH AND TREATMENT, 2012, 44 (02): : 127 - 132
  • [3] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    Hwang, In Gyu
    Jang, Joung-Soon
    Oh, Sung Yong
    Lee, Suee
    Kwon, Hyuk Chan
    Lee, Gyeong Won
    Go, Seil
    Kang, Myoung Hee
    Cha, Young Joo
    Kang, Jung Hun
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2371 - 2376
  • [4] Phase II trial of bevacizurnab plus gemcitabine in patients with advanced pancreatic cancer
    Kindler, HL
    Friberg, G
    Singh, DA
    Locker, G
    Nattam, S
    Kozloff, M
    Taber, DA
    Karrison, T
    Dachman, A
    Stadler, WM
    Vokes, EE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8033 - 8040
  • [5] Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
    Vittorio Ferrari
    Francesca Valcamonico
    Vito Amoroso
    Edda Simoncini
    Lucia Vassalli
    Patrizia Marpicati
    Giovanni Rangoni
    Salvatore Grisanti
    Guido AM Tiberio
    Franco Nodari
    Carla Strina
    Giovanni Marini
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 57 : 185 - 190
  • [6] Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Tiberio, GAM
    Nodari, F
    Strina, C
    Marini, G
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 185 - 190
  • [7] Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
    Lipton, Allan
    Campbell-Baird, Cynthia
    Witters, Lois
    Harvey, Harold
    Ali, Suhail
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 286 - 288
  • [8] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    [J]. Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [9] Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial
    Ianniello, GP
    Orditura, M
    Rossi, A
    De Vita, F
    Maiorino, L
    Carrozza, F
    Manzione, L
    Catalano, G
    [J]. ONCOLOGY REPORTS, 2001, 8 (05) : 1111 - 1115
  • [10] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
12345